MOTS-c injectable peptide vial

MOTS-c is a mitochondrial-derived peptide studied for insulin sensitivity, metabolism, and exercise capacity — often called an “exercise mimetic.” Human evidence is early-stage and it is used as a metabolic adjunct. Ivologist prescribes it after a medical telehealth consultation. MOTS-c is not FDA-approved.

MOTS-c Therapy

A clinician-guided MOTS-c protocol for metabolic-health goals, prescribed in 12-week cycles. MOTS-c is studied for insulin sensitivity and exercise capacity; human evidence is early-stage. Includes provider consultation, medication supply, and ongoing care guidance.

Choose your cycles3 × 5 mL vials per cycle
1 cycleLaunch special
$899$800

12 weeks · 1 × 12-week cycle · $800/cycle

You save $99

Every cycle includes
  • Clinician consultation
  • Peptide medication
  • Free shipping
  • May require labs

One-time payment, not a subscription. Up to 3 cycles per year. A cycle is the program length; your provider decides whether treatment is right for you and sets your dose, schedule and duration. We do not offer clinical trials. Individual results may vary.

  • 43,000+Patients served
  • 4.8Google rating
  • US-licensed503A Pharmacies
Studied for Insulin Sensitivity

In mostly animal and lab research, MOTS-c is studied for how the body handles glucose, through AMPK activation. Human evidence is early-stage.

Studied for Mitochondrial & Metabolic Health

A mitochondrial-derived peptide studied, mostly in animal research, for cellular energy and metabolism.

Clinician-Guided Treatment

Licensed providers determine dosing, frequency, and duration based on medical history and clinical evaluation.

Studied as an “Exercise Mimetic”

In animal studies it switches on pathways normally triggered by physical activity, and it is studied for endurance and recovery.

Can Sit Alongside Broader Care Plans

Your provider decides whether it fits alongside a metabolic or longevity program.

All treatment plans require medical evaluation and approval. Individual results may vary.

Take control of your health in 6 simple, affordable steps

Personalized Intake

1

Tell us about your health, goals, and history through a secure intake questionnaire.

Clinician Review

2

A licensed clinician reviews your information and determines what's right for you.

Diagnostic Lab Testing

3

Baseline lab work checks your health markers before any peptide is prescribed.

Clinical Evaluation

4

A provider reviews your labs with you in a live video visit and confirms your suitability for peptide therapy.

Medication Delivered

5

Your prescribed medication is prepared by a partner pharmacy and shipped to your home.

Ongoing Support

6

Your progress is monitored with follow-ups and adjustments as needed.

How the program works

Built around 12-week cycles

Peptide programs are sold in 12-week cycles (about 3 months). You can buy one cycle or a bundle of up to 3 cycles up front, with a maximum of 3 cycles per year.

Labs and a provider consultation are required.

Every peptide program starts with lab work and a live consultation with a licensed provider before anything is prescribed.

A year on the programUp to 3 cycles · 52 weeks
  1. Lab panel includedCycle 112 weeksOne cycle at a time
  2. Cycle 212 weeksBundle of 2 · save 7.5%
  3. Cycle 312 weeksBundle of 3 · save 12.5%
  • Clinician consultation & follow-up access
  • All peptide medication for the cycle
  • Shipping to your door
  • Injection supplies & dosing guide

Peptide therapy

Not sure which peptide program is right for you?

Talk it through first in a free 15-minute provider consultation. A U.S.-licensed provider will go over your goals and health history, explain how the programs work, and help you decide whether one is right for you before you commit to a cycle. There is no obligation to start treatment.

Book a Free Provider Consultation

Understanding Metabolic and Mitochondrial Health

Metabolism and mitochondrial function shift with age and inactivity. Learn how clinician-guided MOTS-c therapy may support insulin sensitivity, energy, and exercise capacity.

Understanding Metabolic & Mitochondrial Health

Learn about MOTS-c, how it works, and how clinician-guided therapy may support your metabolic goals.

The Physiology

Proposed Mitochondrial Peptide Signaling

Mitochondrial peptide → AMPK activation → Glucose handling + mitochondrial function

MOTS-c is encoded within the mitochondria and, in lab and animal studies, activates AMPK, a key cellular energy sensor. How it works in people is still being researched.

Because in that research it triggers pathways normally switched on by physical activity, it's often described as an “exercise mimetic.”

Symptoms

Symptoms & Signals

Some individuals report patterns such as:

Signs of insulin resistance
Low energy or endurance
Stubborn metabolic weight
Slower recovery from activity
Plateaus despite lifestyle effort

Experiencing multiple patterns may warrant clinician evaluation.

Who Is It For?

Who May Benefit from MOTS-c?

MOTS-c may be considered for adults who are:

Focused on metabolic health or insulin sensitivity
Supporting endurance and recovery
Managing weight as part of a broader plan
Seeking a clinician-guided metabolic adjunct

Clinical evaluation is required. Your eligibility will be determined by a licensed provider.

MOTS-c vs Exercise

MOTS-c vs Exercise Alone

How the two differ. MOTS-c's human evidence is early-stage.

MOTS-c

Studied for activating exercise-related metabolic pathways (AMPK), mostly in animal research.

  • A clinician-guided adjunct
  • Used alongside activity, not instead of it
  • Researched for insulin sensitivity
  • Human evidence: early-stage

Exercise Alone

The foundation of metabolic health.

  • •Essential and irreplaceable
  • •MOTS-c is studied as a complement, not a substitute

MOTS-c is not a replacement for physical activity. Treatment decisions are determined through clinician evaluation.

Protocol

Protocol Philosophy

MOTS-c is studied alongside activity, so providers often pair it with training.

An example, not your plan. This page offers injectable MOTS-c only. The 12-week cycle you choose is the program: clinician consultation, peptide medication and free shipping; labs may be required. It is not a dosing schedule; your provider decides your dose, how often and for how long.

Early (Weeks 1–4)

Injections begin as your provider prescribes, often in the morning, fasted, before exercise.

Build (Weeks 4–8)

Some people report energy or endurance changes. This is not guaranteed.

Review (Weeks 8–12)

Your provider reassesses your metabolic markers and response.

Ongoing

Any longer-term use is your provider's decision, reviewed cycle by cycle.

Responses vary by individual.

Research Findings and Limits

Research Findings and Limits

What MOTS-c has been studied for, and the kind of study behind each:

Animal and lab studiesInsulin sensitivity and glucose handling
Animal studiesEndurance and recovery
Animal studiesFat metabolism
Care planCan sit alongside a metabolic program

Limits of the research. MOTS-c's evidence is mainly laboratory and animal work, and human evidence is early-stage. No outcome is guaranteed.

Individual responses vary.

Designed for Safety.Guided by Clinicians.

  • Not a treatment for diabetes — MOTS-c is early-stage, compounded and not FDA-approved, and never replaces diabetes care
  • Blood sugar is monitored — especially in people with diabetes or prediabetes
  • Gradual, not instant — any response builds over weeks and is not guaranteed; your provider assesses it over a full 12-week cycle

MOTS-c is screened for contraindications (pregnancy and breastfeeding) and blood-sugar concerns before it is prescribed

MOTS-c vial standing on a stone plinth

Serving all 50 States with science-first,
outcome-driven wellness.

Compounded peptides ship from licensed US pharmacies. Certain products and delivery forms may vary by state — our team will help you find the best option for your needs.

Our patients trust us because we combine real medicine with real care.

4.8 average rating

Frequently Asked Questions

Get answers to commonly asked questions.

MOTS-c is a small peptide encoded within the mitochondria that, in lab and animal studies, activates AMPK, a cellular energy sensor. It is studied for metabolic and mitochondrial health and is available as a compounded prescription medication.

It is studied for insulin sensitivity, mitochondrial and metabolic health, endurance, and fat metabolism, used as a supervised metabolic adjunct alongside nutrition and activity.

No. MOTS-c is not FDA-approved. It is compounded by licensed 503A pharmacies and prescribed individually after a medical evaluation.

It is studied, mostly in animal research, for glucose handling via AMPK activation; human evidence is early-stage, so this is not established in people. It is not a treatment for diabetes; blood sugar is monitored, especially in people with diabetes or prediabetes.

It is often described that way because, in animal research, it triggers metabolic pathways normally switched on by physical activity. It complements exercise rather than replacing it.

Still have questions? Contact us